Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03456674 · ClinicalTrials.gov registry record · NA
LaseMD System for the Treatment of Melasma
A NA study of Melasma, sponsored by CynosureLutronic.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03456674 is a NA study of Melasma that is active but no longer recruiting, run by CynosureLutronic. The registered enrollment target is 10 participants, below the 44-participant average among 8 other Melasma trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03456674, a NA study of Melasma, is active but no longer recruiting, sponsored by CynosureLutronic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the clinical outcomes associated with use of the LaseMD Laser System for the treatment of melasma.
Conditions Studied
Interventions
- DEVICE LaseMD System
Study Locations (1)
New York
- Laser and Skin Surgery Center of New York - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-02-07 |
| Est. Completion | 2019-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03456674
The ClinicalTrials.gov registry entry for NCT03456674 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 44-participant average among 8 other Melasma trials with a reported enrollment target (77% lower). The listed sponsor is CynosureLutronic, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Melasma appearing as the primary indexed condition, and to 1 intervention - of which LaseMD System is the first listed.
NCT03456674 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03456674 about?
NCT03456674 is a clinical study titled "LaseMD System for the Treatment of Melasma". This study will evaluate the clinical outcomes associated with use of the LaseMD Laser System for the treatment of melasma.
What is the current status of trial NCT03456674?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2018-02-07. Estimated completion is 2019-06-30.
What conditions does trial NCT03456674 study?
This clinical trial studies the following conditions: Melasma.
What interventions are being tested in trial NCT03456674?
The interventions under investigation include: LaseMD System (DEVICE).
Who is sponsoring clinical trial NCT03456674?
This trial is sponsored by CynosureLutronic, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03456674 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melasma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sylfirm X Radiofrequency Microneedling for the Treatment of Melasma
RECRUITING · NA
-
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
RECRUITING · NA
-
Efficacy and Safety of PiQo4 Device for Treatment of Melasma
COMPLETED · NA
-
Split-face Study Comparing the Cosmetic Efficacy and Tolerability of Two Topical Products in Participants With Moderate Facial Melasma
COMPLETED · NA
-
A Study of the RevLite Laser System for the Treatment of Refractory Mixed Type Melasma
COMPLETED · NA
-
Salicylic Acid Peels Combined With 4% Hydroquinone in the Treatment of Moderate to Severe Melasma in Hispanic Women
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.